Contract award · 16 Jan 2025

Radiopharmaceuticals Treatment of Prostate Cancer (Xofigo) 2025

United Lincolnshire Teaching Hospitals NHS Trust awarded “Radiopharmaceuticals Treatment of Prostate…” to Bayer Public Limited Company for £106k.

No competitionMedical equipment & pharmaceuticalsEast Midlands

Awarded without open competition

Awarded without open competition. The buyer went directly to one or a few suppliers instead of advertising the contract. Procurement rules allow this only in specific cases, such as extreme urgency, when only one supplier can do the work, or for call-offs from an existing framework.

What “without competition” means

Key facts

Buyer
United Lincolnshire Teaching Hospitals NHS Trust · Body governed by public law
Value
£105,600
Procedure
Single tender action (below threshold)
Sector
Medical equipment & pharmaceuticals · Pharmaceutical products (CPV 33600000)
Timeline
  1. Contract date16 Jan 2025
  2. Published24 Jan 2025Published 8 days after the contract date

Description

Provision of radiopharmaceuticals for treatment of prostate cancer - Xofigo. Additional information: Below threshold Direct Award. Bayer PLC are the only supplier of Xofigo and no alternative products are on the market.

About the supplier

More from United Lincolnshire Teaching Hospitals NHS Trust

All contracts

More won by Bayer Public Limited Company

All contracts

Recent medical equipment & pharmaceuticals contracts

Sector overview